Cingulate CING
NASDAQ CING
$4.66 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cingulate (CING) Non Operating Investment Income (2022)

Updated

Cingulate's Non Operating Investment Income was $3,249 in Q3 2022.

Analysis

Cingulate (CING) Non Operating Investment Income (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Cingulate 62.17 Mn 7.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 3,249.00
Jun 30, 2022 -466.00
Mar 31, 2022 -2,948.00
API Access

Cingulate Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CING&period=max&api_key=YOUR_API_KEY